Hepatitis Clinical Trials in San Antonio

Showing 241-260 of 280 trials

Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection

NCT00782353

The purpose of this study is to investigate the safety, tolerability, and antiviral activity of ANA598 in patients with genotype-1 chronic hepatitis C infection.

Chronic Hepatitis C

Hoffmann-La Roche35 participantsStarted Oct 2008

St Louis, Missouri, United States • New York, New York, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 1< 1 mile

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

NCT01250366

The purpose of this study is to determine the Safety and Pharmacokinetics of Multiple Ascending Oral Doses of INX-08189 in Chronically-infected Genotype 1 HCV, Treatment-naïve Subjects.

HCV (Genotype 1)

Bristol-Myers Squibb70 participantsStarted Oct 2010

Los Angeles, California, United States • Plymouth, Minnesota, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPhase 1< 1 mile

Open-Label Hepatic Impairment Study

NCT01497327

This study will be conducted in Hepatitis C positive patients to determine whether the pharmacodynamic effects of PSI-7977 or PSI-352938 are similar to HCV-infected patients with normal hepatic function, which may allow inclusion of patients with cirrhosis and varying degrees of hepatic dysfunction in future clinical studies.

Hepatitis C

Gilead Sciences24 participantsStarted Jul 2011

San Antonio, Texas, United States • San Juan, Puerto Rico, Puerto Rico

Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Open-Label Hepatic Impairment Study

Hepatitis Trials in Other Cities

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

CTS-1027 in Interferon-Naive Hepatitis C Patients

Study of CTS-1027 in Hepatitis C Patients

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

Epidemiological Study in Children and Adolescents With Chronic Hepatitis B

Other Conditions in San Antonio